Emilia Viklund provides a breath test in the instrument PExA in connection with...
Emilia Viklund provides a breath test in the instrument PExA in connection with her own covid.

Photo: Agnes Viklund

News • Alternative to swab

COVID-19 infection detected in breath tests

Traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in microscopically small fluid droplets exhaled during a very short time span.

The measurements were made with the research instrument Particles in Exhaled Air (PExA), developed at Occupational and Environmental Medicine at Sahlgrenska Academy, and with a smaller handheld instrument called the Breath Explor (BE).

Infection spread with exhaled air is well known, but now the researchers show that a few breaths are sufficient for detecting traces of viruses in microscopically small fluid droplets (i.e. particles) exhaled from small airways, at least early in the course of COVID-19.

“We show that aerosol particles with the ribonucleic acid (RNA) virus can be found early in the course of COVID-19. The particles we can detect are very small–less than five micrometers in diameter–and we have here managed to capture particles with RNA virus in just a few breaths,” said Emilia Viklund, a doctoral student in occupational and environmental medicine and lead author of the study.

Affects in the small airways

Of course, this immediately leads to conjecture about possibly replacing unpleasant nasal swab tests with convenient and easy breath tests. However, according to Professor Anna-Carin Olin, the inventor of PExA, that would be extrapolating the findings too far.

“Respiratory viruses such as SARS-CoV-2 are likely to be concentrated mainly in the nose and throat, and it is easiest to take samples from that mucous membrane to detect the infection,” says Professor Olin. “In contrast, the method of taking measurement in exhaled air is a very promising way of studying how the virus affects the small respiratory airways and how this effect changes during the course of the disease. Among other things, we are working on studies of post-COVID conditions using this method.”

Emilia Viklund says, “Methods for studying aerosol particles can be a good way of complementing established methods of measuring and monitoring COVID-19. In general, we can say that analysis of exhaled air has great potential for studying the spread of infection and where the virus is in the respiratory tract.”

Difficult to recruit study subjects

The idea of trying to measure viruses and signs of changes in the small respiratory passages using PExA originated early in 2020, when the pandemic was an established fact. One challenge has been recruiting study subjects early in the course of the disease, despite close collaboration with the research team of the study’s co-author, Professor Johan Westin, in the Department of Infectious Diseases.

In an initial small study involving only 10 subjects conducted in the autumn of 2020, only one of the samples was positive. The researchers believe this resulted from conducting measurements too late in the course of the disease. In collaboration with Sahlgrenska University Hospital, which allowed parallel measurement in connection with employees taking polymerase chain reaction (PCR) tests on the hospital grounds, the study eventually evolved to include more subjects in an earlier stage of the disease. These measurements were conducted in the spring of 2021 on medical professionals who had just submitted positive PCR samples for COVID-19.

Three different techniques were used to collect the samples: 20 normal breaths; a technique in which study subjects briefly hold their breath after a very deep exhalation; and a technique in which the study subject coughed three times into the instrument.

Extremely small samples

The research shows unsurprisingly that coughing generated the most positive breath samples collected with PExA (8 of 25), followed by deep breathing (3 of 25) and regular breathing (2 of 25). Two positive aerosol samples from normal respiration were also generated when collected with the instrument Breath Explor, although these came from individuals who were separate from the PExA findings with normal respiration.

“The quantity of aerosol particles we needed for the test was about one 10-millionth of the amount from nasal swab samples needed to detect viral RNA in regular respiration with PCR analysis,” says Anna-Carin Olin. “The findings from the deep-breathing maneuver came as a surprise, the amount of sample is minute. Fluid droplets that one exhales after deep breathing form largely in the small airways, where it is known that the virus can cause great damage. As a result, it would be exciting to further study the findings in the exhaled air in relation to disease progression.”

The findings have been published in the journal Influenza and Other Respiratory Viruses.

Source: University of Gothenburg


More on the subject:
Read all latest stories

Related articles


News • To enter human cells

SARS-CoV-2 hijacks antiviral human proteins

SARS-CoV-2 depends on the broadly antiviral interferon-induced human transmembrane proteins , to enter human cells and replicate inside them.


News • After hospitalization

Covid: two years later, half of patients still have symptoms

Two years after infection with COVID-19, half of patients who were admitted to hospitals still have at least one symptom, according to the longest follow-up study to date.


News • UV sterilization

Ultraviolet disinfection against Covid-19: Study gives new insights

UV radiation is one of the go-to methods for preventing the spread of SARS-CoV-2. But what UV dosage kills the virus? What wavelength? How long? A new study answers many of those questions.

Related products

Beckman Coulter – SARS-CoV-2 Assays


Beckman Coulter – SARS-CoV-2 Assays

Beckman Coulter Diagnostics
Lifotronic  SARS-CoV-2 Antibody Detection Kit


Lifotronic SARS-CoV-2 Antibody Detection Kit

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Antigen


Lifotronic – SARS-CoV-2 Antigen

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit


Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Lifotronic Technology Co., Ltd
Subscribe to Newsletter